AbbVie forecasts Q2 2026 earnings AbbVie delivered strong Q2 2026 results, exceeding expectations. The company reported double-digit sales growth and advancement in its pipeline of innovative medicines. AbbVie forecasts 2026 adjusted EPS of $13.87-$14.07 and Q3
AbbVie forecasts Q2 2026 earnings
AbbVie delivered strong Q2 2026 results, exceeding expectations.
The company reported double-digit sales growth and advancement in its pipeline of innovative medicines.
AbbVie forecasts 2026 adjusted EPS of $13.87-$14.07 and Q3 EPS of $3.84-$3.88.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
